The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality: long-term outcomes from the UK Biobank

Author:

Chieng David123ORCID,Canovas Rodrigo45,Segan Louise123ORCID,Sugumar Hariharan123ORCID,Voskoboinik Aleksandr123,Prabhu Sandeep123ORCID,Ling Liang-Han123ORCID,Lee Geoffrey36,Morton Joseph B36ORCID,Kaye David M127,Kalman Jonathan M367ORCID,Kistler Peter M1237ORCID

Affiliation:

1. Clinical Electrophysiology Research Laboratory, Baker Heart and Diabetes Research Institute , 55 Commercial Road, Melbourne 3004 , Australia

2. Department of Cardiology , Alfred Hospital, 55 Commercial Road, Melbourne 3004 , Australia

3. Department of Medicine, University of Melbourne , Parkville 3010 , Australia

4. Cambridge Baker Systems Genomics Initiaive , 75 Commercial Road, Melbourne 3004 , Australia

5. Baker Department of Cardiometabolic Health , 75 Commercial Road, Melbourne 3004 , Australia

6. Royal Melbourne Hospital , 300 Grattan Street, Melbourne 3010 , Australia

7. Department of Medicine, Faculty of Medicine, Monash University , Melbourne 3800 , Australia

Abstract

Abstract Aims Epidemiological studies report the beneficial effects of habitual coffee consumption on incident arrhythmia, cardiovascular disease (CVD), and mortality. However, the impact of different coffee preparations on cardiovascular outcomes and survival is largely unknown. The aim of this study was to evaluate associations between coffee subtypes on incident outcomes, utilizing the UK Biobank. Methods and results Coffee subtypes were defined as decaffeinated, ground, and instant, then divided into 0, <1, 1, 2–3, 4–5, and >5 cups/day, and compared with non-drinkers. Cardiovascular disease included coronary heart disease, cardiac failure, and ischaemic stroke. Cox regression modelling with hazard ratios (HRs) assessed associations with incident arrhythmia, CVD, and mortality. Outcomes were determined through ICD codes and death records. A total of 449 563 participants (median 58 years, 55.3% females) were followed over 12.5 ± 0.7 years. Ground and instant coffee consumption was associated with a significant reduction in arrhythmia at 1–5 cups/day but not for decaffeinated coffee. The lowest risk was 4–5 cups/day for ground coffee [HR 0.83, confidence interval (CI) 0.76–0.91, P < 0.0001] and 2–3 cups/day for instant coffee (HR 0.88, CI 0.85–0.92, P < 0.0001). All coffee subtypes were associated with a reduction in incident CVD (the lowest risk was 2–3 cups/day for decaffeinated, P = 0.0093; ground, P < 0.0001; and instant coffee, P < 0.0001) vs. non-drinkers. All-cause mortality was significantly reduced for all coffee subtypes, with the greatest risk reduction seen with 2–3 cups/day for decaffeinated (HR 0.86, CI 0.81–0.91, P < 0.0001); ground (HR 0.73, CI 0.69–0.78, P < 0.0001); and instant coffee (HR 0.89, CI 0.86–0.93, P < 0.0001). Conclusion Decaffeinated, ground, and instant coffee, particularly at 2–3 cups/day, were associated with significant reductions in incident CVD and mortality. Ground and instant but not decaffeinated coffee was associated with reduced arrhythmia.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

Reference37 articles.

1. Cardiovascular effects of caffeinated beverages;Voskoboinik;Trends Cardiovasc Med,2019

2. A survey of physician advice about caffeine;Hughes;J Subst Abuse,1988

3. Caffeine and arrhythmias: time to grind the data;Voskoboinik;JACC Clin Electrophysiol,2018

4. Coffee and tea on cardiovascular disease (CVD) prevention;Chieng;Trends Cardiovasc Med,2021

5. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice;Visseren;Eur Heart J,2021

Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3